Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.12B |
| 2 |
Apple
AAPL
|
+$963M |
| 3 |
Wells Fargo
WFC
|
+$647M |
| 4 |
ConocoPhillips
COP
|
+$632M |
| 5 |
UnitedHealth
UNH
|
+$490M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$963M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$907M |
| 3 |
KKR & Co
KKR
|
+$906M |
| 4 |
CRH
CRH
|
+$670M |
| 5 |
Meta Platforms (Facebook)
META
|
+$593M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.44% |
| 2 | Healthcare | 8.01% |
| 3 | Financials | 6.79% |
| 4 | Industrials | 6.22% |
| 5 | Consumer Discretionary | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
B
3826
DELISTED
Barnes Group Inc.
B
| $1.24M | ﹤0.01% |
+29,917
| New | +$1.13M |
|
3827
Century Casinos
CNTY
$34M
| $1.24M | ﹤0.01% |
446,808
+413,128
| +1,227% | +$1.2M |
|
|
QVCGA
3828
DELISTED
QVC Group Inc Series A
QVCGA
| $1.24M | ﹤0.01% |
39,265
-72,572
| -65% | -$3.02M |
|
3829
Nuvation Bio
NUVB
$2.2B
| $1.23M | ﹤0.01% |
422,312
-481,978
| -53% | -$1.47M |
|
3830
State Street SPDR Portfolio S&P 500 High Dividend ETF
SPYD
$7.62B
| $1.23M | ﹤0.01% |
30,629
+9,490
| +45% | +$381K |
|
|
TMHC
3831
DELISTED
Taylor Morrison
TMHC
| $1.23M | ﹤0.01% |
22,222
-56,603
| -72% | -$3.23M |
|
3832
PUT
Array Technologies
ARRY
$803M
| $1.23M | ﹤0.01% |
120,000
-227,300
| -65% | -$2.89M |
|
3833
PUT
Copart
CPRT
$27B
| $1.23M | ﹤0.01% |
22,700
-18,100
| -44% | -$988K |
|
3834
PMV Pharmaceuticals
PMVP
$59.2M
| $1.23M | ﹤0.01% |
758,740
+103,279
| +16% | +$186K |
|
3835
Metagenomi Therapeutics
MGX
$44.8M
| $1.23M | ﹤0.01% |
313,162
-434,386
| -58% | -$2.98M |
|
3836
Motorcar Parts of America
MPAA
$254M
| $1.22M | ﹤0.01% |
198,163
-173,633
| -47% | -$997K |
|
3837
Immuneering
IMRX
$267M
| $1.22M | ﹤0.01% |
953,226
+889,964
| +1,407% | +$1.46M |
|
|
TIXT
3838
DELISTED
TELUS International
TIXT
| $1.22M | ﹤0.01% |
210,644
+130,710
| +164% | +$913K |
|
3839
First Hawaiian
FHB
$3.38B
| $1.22M | ﹤0.01% |
+58,636
| New | +$1.23M |
|
3840
Columbia Banking Systems
COLB
$8.84B
| $1.22M | ﹤0.01% |
61,154
-225,927
| -79% | -$4.29M |
|
3841
JetBlue
JBLU
$2.28B
| $1.21M | ﹤0.01% |
198,840
-1,198,978
| -86% | -$7.23M |
|
3842
PUT
Savara
SVRA
$1.12B
| $1.21M | ﹤0.01% |
+300,000
| New | +$1.33M |
|
3843
Vera Therapeutics
VERA
$2.3B
| $1.21M | ﹤0.01% |
33,397
-1,394
| -4% | -$55.3K |
|
3844
CALL
Glaukos
GKOS
$9.83B
| $1.21M | ﹤0.01% |
+10,200
| New | +$1.08M |
|
3845
PUT
Shake Shack
SHAK
$2.53B
| $1.21M | ﹤0.01% |
13,400
-3,600
| -21% | -$351K |
|
3846
Lifestance Health
LFST
$4B
| $1.2M | ﹤0.01% |
245,366
-177,781
| -42% | -$1.07M |
|
|
NLOP
3847
Net Lease Office Properties
NLOP
$173M
| $1.2M | ﹤0.01% |
48,907
-55,340
| -53% | -$1.31M |
|
3848
Mission Produce
AVO
$1.11B
| $1.2M | ﹤0.01% |
121,807
+102,993
| +547% | +$1.18M |
|
|
GMS
3849
DELISTED
GMS Inc
GMS
| $1.2M | ﹤0.01% |
14,841
-221,448
| -94% | -$20.4M |
|
3850
Citius Pharmaceuticals
CTXR
$15.6M
| $1.2M | ﹤0.01% |
+81,954
| New | +$1.47M |
|
Similar funds
Millennium Management's Q2 2024 Portfolio in Review
As of Q2 2024, Millennium Management held 6,803 positions worth $216B, down 7.8% from $234B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Millennium Management withdrew a net $24.5B in Q2 2024, closing 995 positions and reducing 2,549 holdings. Its most notable exit was Pioneer Natural Resource Co., an estimated $907M position sold in full.
By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 8.5% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Millennium Management opened a new position in QXO Inc worth $20.6M.
- Millennium Management's largest Q2 2024 buy was QXO Inc: 2,219,158 shares worth $20.6M.
- Millennium Management added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $1.12B increase.
- Millennium Management's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $963M.
- Millennium Management fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $907M.
- Millennium Management's ten largest holdings make up 16% of its $216B portfolio in Q2 2024.
- Millennium Management opened 661 new positions and closed 995 in Q2 2024.
- Millennium Management's portfolio value fell 7.8% quarter-over-quarter to $216B.
Based on Millennium Management's 13F filing for Q2 2024, filed 14 Aug 2024.